Li C, Tian Y, Zheng Y, Yuan F, et al. Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05). J Clin Oncol 2024 Oct 9:JCO2400795. doi: 10.1200/JCO.24.00795.
PMID: 39383487